Antitoxins encoded by type II toxin -antitoxin (TA) modules neutralize cognate toxins by direct proteinprotein contact and in addition, regulate TA operon transcription by binding to operators in the promoter regions. On top of the simple negative feed-back regulation, canonical type II TA operons are regulated by a mechanism called 'Conditional Cooperativity'(CC). In CC, the cellular toxin:antitoxin (T:A) ratio controls the transcription-rate such that low T:A ratios favour repression and high T:A ratios favour de-repression of TA operon transcription. Here a new molecular mechanism that secures selective synthesis of antitoxin in the presence of excess toxin was unravelled. The hicAB locus of E. coli K-12 encodes HicA mRNase and HicB antitoxin. It was shown that hicAB is transcribed by two promoters, an upstream one that is activated by CRP-cAMP and competence factor Sxy and a downstream one that is autorepressed solely by HicB. Excess HicA destabilizes the HicB•operator complex in vitro and consistently, activates hicAB transcription in vivo. Remarkably, the hicAB transcript synthesized from the HicBcontrolled promoter produces HicB but not HicA. Thus, the HicA-mediated derepression of hicAB transcription provides a mechanism that conditionally and selectively stimulates synthesis of HicB antitoxin under conditions of excess HicA toxin.
Introduction
Prokaryotic toxin -antitoxin (TA) modules usually code for two components, a 'toxin' that inhibits cell growth, and an antitoxin that counteracts the cognate toxin. The molecular mechanisms by which antitoxins counteract toxins have been used to divide TA modules into different types (Hayes, 2003) . Thus, type I TAs encode small antisense RNA antitoxins that inhibit translation of toxinencoding mRNAs while type II TAs encode protein antitoxins that neutralize cognate toxins by direct proteinprotein contact (Gerdes et al., 1997; Gerdes and Maisonneuve, 2012) . Type III antitoxins are small RNAs that directly combine with and neutralize their cognate toxins. Based on toxin similarities, the most abundant TA types, type I and II, have in turn, been divided into families or, when relevant, superfamilies that cover large evolutionary distances Gerdes and Wagner, 2007; Shao et al., 2011) .
Type II TAs are abundantly present in free-living prokaryotes, often in perplexingly high numbers. For example, Mycobacterium tuberculosis has at least 88 type II TA loci belonging to many different families Ramage et al., 2009) . Most type II toxins inhibit cell growth by inhibiting translation. Thus, the most abundant type II toxins, encoded by vapBC loci, inhibit translation by site-specific cleavage of tRNAs or rRNAs (Winther and Gerdes, 2011; Winther et al., 2013 Winther et al., , 2016 while RelE and MazF inhibit translation by ribosome-dependent and independent mRNA cleavage respectively Zhang et al., 2003) . Consistently, ectopic production of RelE or MazF leads to a bacteriostatic condition from which the cells can be efficiently resuscitated (Pedersen et al., 2002; Christensen et al., 2003; Fu et al., 2009) . A large body of evidence support, directly or indirectly, that type II TA modules may contribute to multidrug tolerance (persistence) (Moyed and Bertrand, 1983; Keren et al., 2004; Shah et al., 2006; Schumacher et al., 2009; Maisonneuve et al., 2011; Fridman et al., 2014; Schumacher et al., 2015) . Persisters constitute minute fractions of rapidly growing ensembles of cells and have transiently entered a slow-growing or dormant state in which they are tolerant to antibiotics (Bigger, 1944; Balaban et al., 2004) . We showed that high ppGpp levels in single cells induce the persistent state and that persistence depended on induction of TA gene transcription (Maisonneuve et al., 2013) . Type II TA modules are also required for Salmonella typhimurium to form persister cells within macrophages and for survival within epithelial cells (Helaine et al., 2014; Lobato-Marquez et al., 2015) and have been implicated in persistence and virulence of M. tuberculosis (Tiwari et al., 2015; Torrey et al., 2016) .
Due to the involvement of type II TAs in virulence and antibiotic tolerance, it is important to understand how the genes are regulated. Almost all antitoxins negatively repress type II TA operon transcription via binding to classical operators in the promoter regions (Page and Peti, 2016) . Usually, the toxins function as co-repressors of transcription -that is -the TA complexes repress transcription more efficiently than the antitoxins alone by increasing the cooperativity of antitoxin binding to operators. Most canonical type II TA modules, such as ccdAB, phd/doc, mazEF and relBE (Afif et al., 2001; Overgaard et al., 2008; Garcia-Pino et al., 2010; Zorzini et al., 2015) , are in addition regulated by a phenomenon that we called 'conditional cooperativity' (CC) (Overgaard et al., 2008) . CC denotes the phenomenon that the toxin:antitoxin ratio determines whether the toxin functions as a co-repressor or de-repressor of TA operon transcription. When the toxin:antitoxin ratio is low, the toxin functions as a co-repressor, resulting in strong transcriptional repression. In contrast, high toxin:antitoxin ratios (>1) leads to destabilization of the TA complex bound to the promoter region in vitro and strong induction of TA transcription in vivo (Page and Peti, 2016) . There are also examples in which an antitoxin represses TA operon transcription independently of the toxins, that is, the toxin does not function as a co-repressor Ruangprasert et al., 2014; Bibi-Triki et al., 2014) and in one of these cases (mqsRA of E. coli K-12) toxin excess derepresses TA operon transcription .
hicAB loci constitute a large family of type II TA modules with many members in both bacteria and archaea (Makarova et al., 2006; Jørgensen et al., 2009; Butt et al., 2014; Bibi-Triki et al., 2014) . HicA toxins have a double-stranded RNA-binding fold while HicB antitoxins have a Helix-Turn-Helix (HTH) DNA-binding domain fused to a degraded RNase H fold lacking catalytic residues (Fig. 1A) . We showed previously that hicAB of Escherichia coli K-12 constitutes a bona fide TA locus: ectopic expression of HicA mediated ribosomeindependent mRNA cleavage and concomitant global inhibition of translation while expression of HicB counteracted HicA-mediated inhibition of translation (Jørgensen et al., 2009) . Moreover, HicB could resuscitate cells inhibited by HicA, showing that ectopic production of HicA induced a bacteriostatic condition, consistent with the contribution of hicAB to persistence (Maisonneuve et al., 2011) . Nutritional stresses activated hicAB transcription by a Lon-dependent mechanism, supporting the proposal that HicB autorepresses hicAB transcription and that Lon degrades HicB (Jørgensen et al., 2009) . Interestingly, in E. coli, the competence factor Sxy induced transcription of hicAB by a mechanism that depended on CRP and cAMP (Jaskolska and Gerdes, 2015; Sinha et al., 2009) .
In most type II TA modules, the antitoxin is encoded by the first gene (Pandey and Gerdes, 2005) . However, toxin-encoding gene hicA is located upstream of the antitoxin-encoding gene hicB (Fig. 1A) . This 'reversed' gene-order is conserved in all modules of the widespread hicAB family that have many members in both bacteria and archaea (Makarova et al., 2006; Jørgensen et al., 2009) . Several subfamilies (i.e., higBA and mqsRA) of the relBE super-family exhibit reversed geneorder and it is not known if the reversed gene-order seen with some type II TA modules is related to specific functional or regulatory properties.
Here, we show that the hicAB operon of E. coli K-12 has two promoters that are differentially regulated by a mechanism that favours synthesis of antitoxin in the presence of excess toxin. The upstream promoter is activated by Sxy and CRP-cAMP while the downstream promoter is autoregulated by HicB that binds to an operator in the promoter region. Unexpectedly, HicA does not function as a co-repressor of transcription. However, excess of HicA destabilizes the HicB•operator complex in vitro and, consistently, activates hicAB transcription in vivo. Remarkably, the hicAB transcript synthesized from the downstream, HicB-regulated promoter produces HicB but not detectable levels of HicA. Thus, the HicBcontrolled promoter therefore provides a mechanism that conditionally and selectively stimulates synthesis of HicB when HicA is in excess.
Results

hicAB operon is transcribed by two different promoters
Overproduction of Sxy stimulated hicAB transcription and, consistently, the hicAB promoter region encodes a Sxy-and CRP-dependent CRP-S motif (Fig. 1A,B ) (Sinha et al., 2009) . To analyse the hicAB promoter, we used primer extension analysis. To this end, we inserted DNA fragments into plasmid pGH254, a low-copynumber lacZ transcriptional fusion vector (Supporting Information Table S1 ), thereby generating lacZ fusions that later would allow for quantification of hicAB transcription. The longest fragment chosen (F1) encompassed the entire promoter region located between the upstream gene (yncJ) and hicA plus five additional codons of hicA, a 5 0 -shortened fragment (F3) lacked the CRP-S site and a third fragment had base changes in the 210 box of the CRP-S dependent promoter (F1 M1 ;
Figs. 1B and 2A). Using a primer that annealed to the hicA-lacZ junction of the fusion plasmids, we performed extension analysis of total RNA prepared from MG1655 (wt strain) carrying the three corresponding plasmids plus a plasmid that conditionally could produce Sxy.
With the F1 fragment, before induction of Sxy, P1 activity was below a detectable level (Fig. 2B, right  panel) . Induction of sxy, however, gave rise to a signal that corresponded to an mRNA 5 0 -end originating from the CRP-S dependent promoter (P1). Deletion of the CRP-S site or mutation of the corresponding 210 A. Region of the E. coli K-12 chromosome encoding the hicAB operon. CRP-S denotes a CRP-cAMP binding site whose activity is stimulated by the competence factor Sxy; SD: Shine & Dalgarno sequence; dsRNB: double stranded RNA binding domain; RNase H' denotes a partial RNase H fold; HTH: Helix-Turn-Helix. B. DNA sequence of the region between yncJ and hicA including the first 40 nucleotides of hicA. The CRP-S site is underlined, P1 and P2 indicate transcriptional start sites of the two hicAB promoters. hicO indicates the inverted repeat to which HicB binds. Red arrows indicate the 5 0 (F) and 3 0 (R) ends of DNA fragments inserted into lacZ fusion vectors. M1 denoted a 6 bp change in the 210 element of P1 (from TATTTT to GGCCCG) and M2, base changes in both legs of hicO inverted repeat to guanine residues (residues for mutation are denoted in red). C. Schematic view of fragments cloned into the transcriptional lacZ fusion vector pGH254 and their LacZ activities (Miller units 6 1 standard deviation) in the strains indicated. Strains used: wt: MG1655Dlac; DhicAB: MG1655DlacDhicAB; DhicAB 1 hicB: MG1655DlacDhicAB carrying pMJ331 (pBAD::hicB).
sequence totally abolished P1 transcription, confirming that P1 is activated by Sxy and, by inference, by CRPcAMP. Surprisingly, the analysis also revealed an mRNA 5 0 -end located just one nucleotide upstream of the Shine & Dalgarno (SD) element of hicA, originating from a promoter that we call P2 (Figs. 1A, B and 2). P2 activity was not affected by induction of sxy, nor by the mutation in F1 M1 or the deletion in F3 (Fig. 2B) , showing that P2 activity is not regulated by Sxy.
The P2 promoter is autoregulated
We then analysed transcription originating from the above-described three fragments ( Fig. 2A ) in a strain that lacked the hicAB operon. In this strain, P2 activity clearly increased, consistent with autoregulation of the hicAB operon ( Fig. 2B , middle panel). To analyse P2 quantitatively, we expanded our series of transcriptional lacZ::hicA fusions. In the wt strain, fragments F1 to F4 all expressed modest but similar levels of LacZ activities ( Fig. 1C ; 120 Miller Units), showing that, during steady-state, P2 is driving transcription of hicAB. The activity expressed by the shortest truncation F5 was close to the basal level of the fusion vector, supporting the assignment of the 210 and 235 promoter elements of P2 (Fig. 1B,C) . Bioinformatic analysis using the EMBOSS package (Rice et al., 2000) revealed that the HicB antitoxin contains a HTH motif in its C-terminus. Moreover, the promoter region contains an inverted repeat overlapping with the 235 sequence of P2 that we call hicO (Fig.  1A,B) , raising the possibility that HicB dimers, or the HicAB complex, autoregulates P2 via binding to hicO. Supporting this proposal, deletion of hicAB caused a significant increase in promoter activity (8-fold) in all strains that had an intact P2 promoter (Fig. 1C) . Moreover, the primer extension analysis also showed that P2 activity was stimulated by deletion of hicAB (Fig. 2B) , again indicating autoregulation of P2.
HicB binds to hicO in the P2 region
We introduced base-changes in both arms of hicO (Fig.  1B) and investigated the effect of the mutations in vivo and in vitro. Indeed, the hicO mutation (M2) totally abolished regulation by chromosome-encoded hicAB (hicO M2 ; pKT30 in Fig. 1C ). In the absence of hicAB, the promoter carrying the M2 mutation exhibited a 2-fold increased activity as compared to the wt promoter (compare pKT30 and pKT18 in Fig. 1C ). We hypothesise that the mutation M2 in the 235 element of P2 (from TAAACA to TGGACA) increases the activity of the promoter due to an increased match with the consensus 235 sequence (TTGACA). A. Structure of plasmids used for primer extension analysis: pKT18 (F1) contains the entire regulatory region; pKT20 (F3) lacks the CRP-S site; pKT70 (F1M1) carries the entire promoter region with a 210 mutation in P1. Specific sequences for each fragment are shown in Fig. 1B . B. Primer extension analysis of total RNA prepared from MG1655 DhicAB (DhicAB, middle3 panel, lanes 5-10) or MG1655 (wild type, right panel, lanes 11-16). Cultures were subjected to sxy expression from plasmid pMJ251 (lanes 6, 8, 10, 12, 14 and 16 ) and compared to strains carrying pMG25 as the vector control (lanes 5, 7, 9, 11, 13 or 15). Strains also harboured one of three lacZ fusion plasmids indicated in A. The extension primer (Primer 28, Supporting Information Table S3 ) is shown as an arrow pointing left-ward and was designed to anneal to the hicA-lacZ junction, 34 bp downstream of the hicA start-codon. Lanes 1-4 show sequencing reactions while lane 17 contained the phosphorylated Primer 28.
Gel-shift analysis revealed that indeed HicB bound specifically to a hicO-encoding DNA fragment and the M2 mutation abolished the binding (Supporting Information Fig. S1 ). Finally, the binding site of HicB in the hicAB promoter region was determined by in vitro DNA foot printing. A protected region covered the hicO inverted repeat (Supporting Information Fig. S2 ). No other sites were protected, suggesting that a single hicO inverted repeat forms the HicB binding site (Fig. 1B) .
HicA does not function as a co-repressor of P2
Overexpression of HicB from a high-copy plasmid (pMJ331-pBAD::hicB) in the DhicAB strain strongly repressed P2 activity, raising the possibility that HicA is not required for repression (Fig. 1C, right column) . To see if HicA is involved in repression of P2 in a native genetic setting, we fused the entire hicAB operon to lacZ immediately downstream of hicB, thus to obtain a measure of the transcription-rate of the intact hicAB operon (Fig. 3Ai) . Then we abolished hicA translation in the operon fusion by changing the native GTG startcodon of hicA to CTG (Fig. 3Aii) . Assuming that this minimal change of the hicAB mRNA would interfere with hicA translation only, comparison of the transcriptional activities expressed by the two otherwise isogenic lacZ fusions in a DhicAB strain in which HicA and HicB are produced solely from the plasmids should reveal if HicA is involved in transcriptional control of hicAB. Indeed, the lack of HicA conferred by the hicA start-codon mutation did not significantly change the hicAB transcriptionrate, supporting that HicA does not act as a corepressor of P2 (Fig. 3A) .
To obtain more direct support for this inference, we used a biochemical approach. First, to construct a nontoxic HicA variant that could be purified, we changed conserved residues in HicA (Supporting Information Fig.  S3A ). Changing the proline and arginine residues at 136 and 137 to alanine abolished HicA-mediated growth-inhibition, both in wt and in DhicAB strains (Supporting Information Fig. S4) and His6-HicB were overexpressed together, the two proteins co-purified, showing that the HicA M3 •HicB interaction was not disrupted by the amino acid residue changes (Supporting Information Fig. S5 ).
To perform gel-shift assays, native HicB and a hicOencoding DNA fragment (called hicO 150 ) were also purified. As expected, HicB by itself shifted hicO 150 in a concentration-dependent pattern (Fig. 3B) . The highest concentration of HicB that did not shift hicO 150 was then incubated with increasing concentrations of HicA. However, even a fourfold excess of HicA M3 relative to HicB was not able to shift hicO 150 (Fig. 3C) , Thus, both in vivo and in vitro data support that HicA does not function as a co-repressor of P2.
HicA conditionally derepresses P2 by destabilization of the hicO•HicB complex
Even though HicA did not function as a co-repressor of transcription, it was still possible that HicA could destabilize HicB•hicO. First, we investigated if HicA overexpression derepressed the hicAB promoter in vivo.
Overexpression of HicA M3 in a wt strain also carrying a hicA::lacZ transcriptional reporter plasmid (pKT18 in Fig. 1C ) indeed resulted in a strong increase in promoter activity (Fig. 4A) . Moreover, gel-shift analysis A. Genetic structure and LacZ activities TB28DhicAB carrying transcriptional lacZ fusions. Both fusions contain the entire hicAB operon with lacZ transcriptionally fused downstream of hicB, pKT120 in (i) contains the native GTG start codon of hicA, while pKT119 has a CTG start-codon mutation in hicA (ii). B. HicB binds to hicO. Titration of HicB against [4 nM] of a 32 Plabelled DNA-fragment (hicO 147 ) encoding the entire regulatory region of the hicAB operon from position 2132 to 115 relative to the start of hicA coding region (F2 Fig. 1B ). HicB concentrations increases by twofold in each successive lane from left to right, the highest concentration being 0.8 mM (lanes 3 to 12). Lanes 2 and 13 contain no protein. C. HicA does not increase binding of HicB to hicO. The hicO 147 fragment was incubated in the absence (2) or presence (1) of 12.5 nM HicB, a concentration that did not shift the hicO 147 fragment, then HicA M3 was added to obtain a series of samples with increasing HicA:HicB ratio. HicA concentrations used in nM: 1.56, 3.123, 6.25, 12.5, 25 and 50.
Excess HicA activates synthesis of HicB 785
showed that an excess of HicA destabilized the HicB•DNA complex. Thus, HicB•hicO complex was stable when the HicB:HicA molar ratio was 1:1 or less. Strikingly, however, at a 1:2 ratio and above, the complex was destabilised (Fig. 4B) . We conclude that the P2 promoter is negatively autoregulated by HicB by itself and that HicA derepresses P2 by destabilizing the HicB•hicO complex at high HicA:HicB ratios.
hicA of the P2 transcript is not translated
The transcript generated by P2 has an unusually short 5 0 -end untranslated leader region (5 0 -UTR) initiating just 1 base upstream of the SD of hicA (Fig. 1B) , raising the possibility that translation of hicA would be affected. To investigate this, we generated a series of translational fusions between hicA and lacZ that are isogenic with the transcriptional fusions described above (Fig. 5A ). As expected, overproduction of Sxy induced HicA-LacZ production from translational fusions possessing the CRP-S site required to activate P1 (pKT14 and pKT15); this was irrespective of the absence or presence of hicAB on the chromosome (Fig. 5B) . Importantly, the hicA::-lacZ translational fusions that lacked the CRP-S site or had P2 only (pKT16 and pKT59) were not translated, neither in the wt nor in the DhicAB strain. These results indicate that the P1 and P2 generated transcripts are translated at highly different rates. To strengthen this proposal, we generated constructs in which the P1 and P2 promoters were precisely replaced by the synthetic, IPTG inducible pA1/O3 promoter (Lanzer and Bujard, 1988) . Simultaneously, hicA was translationally fused to lacZ (Fig. 5C ). As seen, the IPTG inducible transcript isogenic with the P2 transcript did not allow translation of hicA at a detectable level (pKT79 in Fig. 5C ) whereas the transcript isogenic with the P1 transcript indeed was translated (pKT80). We included translational hicB::lacZ fusions that produced mRNAs with 5 0 -ends identical to those of the hicA::lacZ translational fusions (Fig. 5E) . In both cases, the hicB reading frames were translated, indicating that the negligible translation of hicA of the P2 transcript (pKT79 in Fig. 5D ) was not due to a general defect of the synthetic mRNA. We conclude that hicA encoded by the P2-generated transcript is translated at a negligible rate while hicB was translated by both transcripts.
Discussion
Toxins encoded by TA modules are highly detrimental to cell growth unless they are counteracted by their cognate antitoxins (Pedersen et al., 2002; Germain et al., 2013) . Here we present evidence for a novel molecular mechanism that secures preferential antitoxin synthesis when the toxin:antitoxin ratio is high. Our transcriptional analyses confirm previous observations (Cameron and Redfield, 2006; Jaskolska and Gerdes, 2015) that hicAB of E. coli is induced by a Sxy, CRP-cAMP and CRP-S dependent mechanism (Figs. 1 and 2) . The Sxydependent promoter P1 generates a hicAB transcript that produces both HicA and HicB (Fig. 5B, E) . Activation of transcription by Sxy depended on the CRP-S site located upstream of the 235 element of P1, as with other Sxy-dependent promoters (Figs. 1C and 5A, B) . CRP-S sites have a base change (as compared to canonical CRP-N sites) that reduces the affinity for CRP-cAMP and Sxy has therefore been proposed to increase the affinity between the CRP-S site and CRPcAMP (Macfadyen, 2000) . However, there is no experimental support for this proposal and it is still not understood how Sxy activates CRP-S dependent promoters.
The second promoter that we called P2, produces a hicAB transcript of which only the hicB cistron can be translated at a detetable level -that is -the transcript gives rise to production of HicB but only very little HicA ( Fig. 5C-E) . P2 activity is repressed by HicB, by a mechanism that does not depend on HicA (Fig. 3) . Rather, HicB itself binds efficiently to the hicO operator overlapping P2 and HicA does not enhance this binding. Remarkably, however, excess HicA stimulated P2 activity in vivo and, consistently, destabilized the HicB•hicO complex in vitro (Fig. 4) thus yielding an explanation of how excess of an inhibitory toxin can stimulate production of cognate antitoxin that neutralizes the toxin.
The model explaining our current understanding of hicAB gene regulation and HicA activation is shown in Fig. 6 . HicB antitoxin binds (as a dimer or multimer of dimers) to hicO overlapping the 235 element of P2 and inhibits initiation of transcription from P2. When HicB is in molar excess of HicA, P2 is strongly repressed by HicB, independently of HicA. However, if for some reason, the HicA:HicB ratio shifts in favour of a high HicA toxin level, HicA destabilizes the HicB•hicO complex and activates P2. The resulting P2 transcript in turn allows for production of HicB, resulting in replenishment of the antitoxin and quenching of HicA toxin.
Destabilization of the TA-operator complexes by excess toxins is an important component of a mechanism that we called 'Conditional Cooperativity' (Overgaard et al., 2008 ) that regulate transcription of many canonical type II TA modules (see Introduction) (Page and Peti, 2016) . Indeed, our work shows that the hicAB operon is regulated very similar to other type II TA operons in which excess toxin derepresses transcription by destabilization of the TA-operator complex. However, in the hicAB case, HicA toxin does not function as a co-repressor of transcription as seen with in most other ) or the isogeneic DhicAB strain harbouring hicA::lacZ translational fusions pKT14, 15, 16 and 59 with pMJ251 (pMG25::pA1/O4/O3::sxy, indicated by 1Sxy), or the empty vector pMG25 (2Sxy). The strains in (B) were grown on nutrient agar supplemented with antibiotic, IPTG 200 mM to induce sxy and X-gal 40 mg ml 21 and grown at 378C overnight. C. Schematics of hicA::lacZ translational fusions in which the PA1/O4 promoter replaces P2 (pKT79) or P1 (pKT80), thus to generate mRNA 5 0 ends that exactly corresponds to the P2 and P1 transcripts. D. As for C, but with lacZ fused to hicB. Vectors also harboured the hicA M3 mutation to protect against possible HicA toxicity upon induction of IPTG. E. TB28 (MG1655Dlac) cells harbouring the constructs shown in C and D, on a plate containing 10 mM IPTG and 40 mg ml 21 X-gal. TB28 carrying the empty vector plasmid pGH253 are also shown. LacI q , that represses promoter pA01/04, originated from pAL015 (p15A derivative, cat), also present.
Excess HicA activates synthesis of HicB 787 cases, such as, for example, ccdAB, relBE, phd/doc (Afif et al., 2001; Overgaard et al., 2008; De Jonge et al., 2009; Garcia-Pino et al., 2010) . At this time, we can only speculate on the molecular mechanism by which HicA destabilizes the HicB•hicO complex. We did not find evidence that HicA associates stably with the HicB•hicO complex to form a higher order structure (Fig.  4) . It is possible, that the mechanism is related to how the mqsRA TA operon of E. coli K-12 is regulated. Similar to hicAB, MqsR toxin in excess destabilizes the MqsA-operator complex but does not increase the cooperativity of MqsA binding to operator DNA . Structural analyses revealed potential clashes between operator DNA and MqsR when both were bound to MqsA, thus explaining why MqsR destabilizes the MqsR•operator complex [Fig. 5A in (Brown et al., 2013) ].
The molecular mechanisms underlying Conditional Cooperativity varies for the different type II TA families, indicating convergent evolution at the functional level (Page and Peti, 2016) . The biological function of conditional cooperativity is difficult to analyse experimentally. However, our modelling suggested that conditional cooperativity may provide a mechanism for the induction of the transient persister state (Cataudella et al., 2013; Gelens et al., 2013) . Conditional cooperativity may also function in the resuscitation of persister cells and may prevent fortuitous toxin activation (Cataudella et al., 2012) . Similarly, the HicA-mediated feedback loop described here may serve to limit 'cellular noise' and spurious activation of toxin by activating HicB production at high HicA:HicB ratios that potentially would limit cell growth.
A genetic screening for mutations rendering rpoE non-essential in E. coli K-12 revealed that cells carrying a transposon in hicB (formerly ydcQ) can grow in the absence of r E (Button et al., 2007) . Simultaneously, extracytoplasmic stress responses and production of outer membrane vesicles were downregulated. These suppression phenotypes all depended on the presence of hicA -that is -deletion of both hicB and hicA did not suppress the essentiality of r E (Daimon et al., 2015) .
Moreover, moderate overexpression of two RelEhomologous mRNases, HigB and YafQ, also suppressed the essentiality of r E (Daimon et al., 2015) . These results indicate that it is the mRNase activity of HicA that somehow suppresses the essentiality of r E and that deletion of hicB gives rise to a level of hicA activity that allows deletion of rpoE. Our model for hicAB operon regulation (Fig. 6 ) now yields a plausible explanation as to why it is possible to delete the antitoxinencoding gene while retaining the toxin-encoding gene: deletion of hicB obviously derepresses the P2 promoter and gives rise to an increased level of the short hicAB transcript that allows detectable translation of hicB but not hicA (Fig. 5) . We propose that a minute translationrate of hicA of the P2 transcript allows for sufficient production of HicA to provoke suppression of r E essentiality. It is not yet understood why moderate expression of mRNases suppress r E essentiality.
The biological function of Sxy-dependent induction of hicAB is not known (Fig. 5) . However, at least three other type II (chpSB, higBA and prlF-yhaV) and two type I (hokD and hokC) TA modules of E. coli K-12 are induced by Sxy (Sinha et al., 2009) . It has been known for a long time that, in Bacillus subtilis, competent cells enter a growth-arrested state and that these cells are tolerant to antibiotics and possibly other types of environmental stresses (Nester and Stocker, 1963; Johnsen et al., 2009 
Experimental procedures
Strains, plasmids, media and growth conditions
Tables listing strains, plasmids and oligonucleotides are shown in the Supplementary Material. E. coli cultures were grown in Luria-Bertani (LB) at 378C. When applicable, media was supplemented with 30 or 100 mg ml 21 ampicillin, 25 mg ml 21 kanamycin or 25 mg ml 21 chloramphenicol. Expression of the P A1/O4/O3 and P A1/O4 promoters were induced by the addition of 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) unless otherwise stated. Expression of the P BAD promoter was induced by the addition of 0.2% arabinose.
The standard solid medium used to grow cells was nutrient agar (NA) supplemented with appropriate antibiotics incubated for 18 hours at 378C. When applicable, cells were also grown on M9 agarose plates supplemented with 0.4% glycerol, 1 mg ml 21 thiamine with and without 0.1% cassamino acids. To visualize LacZ activity, plates were supplemented with 40 mg ml 21 5-bromo-4-chloro-3-indolylb-D-galactopyranoside (X-gal).
LacZ assay
Overnight cultures were diluted to an OD 600 of 0.005 and grown at 378C in LB with addition of appropriate antibiotics and 0.2% arabinose if required to induce HicB or HicA M3 from pMJ331 and pKT10 respectively. When cultures approached 0.5 OD 600 they were diluted back by 100 fold in fresh medium. Samples were taken over a time course during exponential phase (0.05 to 0.5 OD 600 ). When appropriate, sxy was induced at 0.5 OD 600 from pMJ251 with 1 mM IPTG, samples were taken after 30 minutes of induction at 0.9 OD 600 . LacZ activities were measured according to standard procedure (Miller, 1972) .
Protein purification
HicB and HicA M3 were purified from pKT043 and pKT049 respectively using the toxin-antitoxin purification protocol described previously (Cherny et al., 2007) . Proteins were purified in complex with his-tagged cognate antitoxin or toxin as applicable and separated with urea washes to leave the tagged protein on the column. HicB and HicA
M3
were then refolded with multiple dialysis, once into PBS pH 7.4, 0.1% Triton X-100, 1 mM b-MEOH, twice into PBS pH 7.4, 1 mM b-MEOH and finally into storage buffer (PBS pH 7.4; 20% glycerol; 5 mM DTT).
EMSA
About 1 ml of purified HicB and HicA M3 or storage buffer (PBS pH 7.4; 20% glycerol; 5 mM DTT) were incubated with 3 nM 32 P labelled DNA fragment amplified by PCR with primers 28 and 29 in a 10 ml binding reaction (20 mM Tris-HCl pH 7.5; 100 mM KCl; 2 mM MgCl2; 1 mM DTT; 50 mg ml 21 BSA; 0.1 mg ml 21 sonicated salmon sperm DNA). Samples were ran on 6% acrylamide gels (6% 19:1 Bis-acrylamide; 374 mM Tris-HCL pH8; 13 Tris-glycine (0.25 M Tris Base and 1.92 M Glycine, Fisher scientific 103) in 1 in 13 loading buffer (5% glycerol; 13 binding buffer; 0.02% bromophenol blue; 0.02% xylene cyanol FF). Gels were visualized via phosphoimaging on a Typhoon scanner (GE healthcare). Gel shift data was quantified using ImageQuant.
DNAse I footprint analysis
Samples were prepared as for EMSA then incubated with 0.001 U ml 21 DNase I at 378C for 3 min. The reaction was stopped by addition of sodium acetate to a final concentration of 0.3 M and 2.5 reaction volumes of 96% ethanol to precipitate the DNA. Samples were resuspended in loading buffer (7 M Urea, 20 mM EDTA, Bromophenol Blue and Xylene Cyanol, 0.25% each) and ran on 6% denaturing acrylamide gel along with sequencing reaction ladders (method described for primer extension).
Primer extension analysis
Overnight cultures were diluted to 0.01 OD 600 and grown at 378C in LB with antibiotic selection. When cultures approached 0.5 OD 600 they were diluted back by 10 fold in fresh medium, sxy was induced at 0.5 OD 600 from pMJ251 with 1 mM IPTG. RNA was prepared from samples taken after 30 minutes of induction using a Thermofisher Gene-JET RNA purification kit. RNA quality was assayed by separation on a 1% agarose gel and quantified using a NanoDrop ND-1000 spectrophotometer. Primer extension was performed to determine the 5 0 end of hicAB mRNA, in order to test this in a DhicAB background, a primer was designed that annealed to the beginning of lacZ originating from hicA-lacZ transcriptional fusions. Primer 28 was radiolabeled with Ç-32 P-ATP and incubated at 808C for 5 min with 10 mg total RNA. Once hybridized, RNA was reverse transcribed using Superscript III in 13 First-Strand buffer supplemented with 0.01 M DTT, 1 mM dNTPs and Excess HicA activates synthesis of HicB 789 incubated for 1 hour at 548C. Sequencing reactions were prepared using Ç-32 P-ATP radiolabelled primer 28, and either ddGTP, ddATP, ddTTP or ddCTP. A purified PCR product generated using primers 29 and 28 was used as template DNA. Samples and ladders were fractionated on a 6% denaturing acrylamide gel and were visualized using phosphoimaging on a typhoon (GE healthcare).
